Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ferring permitted to resume marketing of Repronex

Aug. 18, 1997

Alteon receives U.S. patent for AGE cross-link breakers

Aug. 14, 1997

Alkermes issued U.S. patent for ProLease

Aug. 13, 1997

Trovert receives Orphan Drug designation for acromegaly

Aug. 13, 1997

Organon's fertility hormone approved in Canada

Aug. 13, 1997

Crinone approved in Mexico

Aug. 13, 1997

Cangene signs licensing and distribution agreement for Leucotropin

Aug. 12, 1997

RPR seeks U.S. and European approval for estrogen/progestogen transdermal patch

Aug. 12, 1997

Studies imply role of relaxin in infertility treatments

Aug. 12, 1997

Granocyte approved for marketing in 14 additional countries

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...